Synchrony Financial $500 million preferred stock offering
The depositary shares represent an interest in the company’s 8.25% fixed-rate reset non-cumulative perpetual preferred stock
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
REV Group $289.9 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering
Prime Medicine $161 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Market
Gates Industrial $246 million secondary offering
The offering involved 20.125 million ordinary shares
Tenaya Therapeutics $50 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Energisa R$2.5 billion equity offering
The common shares and preferred shares are listed on the São Paulo Stock Exchange
TD SYNNEX $881 million secondary offering
The shares are listed on the NYSE
Immatics $201 million follow-on offering
We advised Immatics on the offering of shares
IDEAYA Biosciences $350 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Alector $75 million stock offering
The common stock is listed on the Nasdaq Global Select Market